Skip to main content

Advertisement

SpringerLink
Log in

Does procalcitonin have a role in the pathogenesis of nasal polyp?

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study is to investigate serum and tissue procalcitonin (PCT) levels in patients with nasal polyps.

Methods

The study was designed to be prospectively controlled and included 26 patients chronic rhinosinusitis with nasal polyp (CRSwNP) endoscopically diagnosed and as a control group 25 chronic rhinosinusitis without nasal polyp (CRSsNP). NP specimens, nasal mucosal tissue and venous blood samples of both groups were collected and PCT levels determined by Elisa method. The results were compared statistically.

Results

Serum PCT values were 1319.5 pg/mL in the NP group and 818.8 pg/mL in the control group. The difference between the groups was statistically significant (p = 0.0001). In the NP group, the average PCT value of the polyp tissue was 1521.5 pg/gr, while the mean PCT value of the control group in the nasal mucosa was 414.6 pg/gr. There was a statistically significant difference between the groups (p = 0.0001). The tissue cut-off value of PCT 750 was significant [area under curve 0.940 (0.863–1.00)]. Serum PCT 950 cut-off value was significant [area under curve 0.860 (0.748–0.972)] activity (CI: 95%).

Conclusions

This is the first study of its kind to objectively examine PCT in the polyp and serum of CRSwNP patients. PCT may serve as a diagnostic biomarker in nasal polyps.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ozcan C, Tamer L, Ates NA, Gorur K (2009) The glutathione-s-transferase gene polymorphisms (Gstt1, Gstm1, and Gstp1) in patients with non-allergic nasal polyposis. Eur Arch Otorhinolaryngol 267:227–232

    Article  PubMed  Google Scholar 

  2. Zhang G, Zhang J, Kuang M, Lin P (2018) The role of TNF alpha polymorphism and expression in susceptibility to nasal polyposis. Immun Invest 47(4):360–371

    Article  CAS  Google Scholar 

  3. Sreeparvathı A. Kalyanikuttyamma LK, Kumar M, Sreekumar N, Veerasigamani N (2017) Significance of blood eosinophil count in patients with chronic rhinosinusitis with nasal polyposis. J Clin Diagn Res 11(2): MC08–MC11

    PubMed  PubMed Central  Google Scholar 

  4. İsmi O, Özcan C, Polat G, Kul S, Gorur K, Pütürgeli T (2017) TNF-α and IL-1 β cytokine gene polymorphism in patients with nasal polyposis. Turk Arch Otorhinolaryngol 55(2):51–56

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bolger WE, Joshi AS, Spear S, Nelson M, Govindaraj K (2007) Gene expression analysis in sinonasal polyposis before and after oral corticosteroids: a preliminary investigation. Otolaryngol Head Neck Surg 137(1):27–33

    Article  PubMed  Google Scholar 

  6. Davidsson A, Danielsen A, Viale G, Olofsson J, Dell’Orto P, Pellegrini C, Karlsson MG, Hellquist HB (1996) Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Clinical relevance and relation to allergy. Acta Otolaryngol 116(4):604–610

    Article  CAS  PubMed  Google Scholar 

  7. Petecchia L, Serpero L, Silvestri M, Sabatini F, Scarso L, Rossi GA (2006) The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol 20(5):445–449

    Article  PubMed  Google Scholar 

  8. Marx D, Tassabehji M, Heer S, Hüttenbrink KB, Szelenyi I (2002) Modulation of TNF and GM-CSF release from dispersed human nasal polyp cells and human whole blood by inhibitors of different PDE isoenzymes and glucocorticoids. Pulm Pharmacol Ther 15(1):7–15

    Article  CAS  PubMed  Google Scholar 

  9. Szabó K, Kiricsi Á, Révész M, Vóna I, Szabó Z, Bella Z, Polyánka H, Kadocsa E, Kemény L, Széll M, Hirschberg A (2013) The – 308 G> A SNP of TNFα is a factor predisposing to chronic rhinosinusitis associated with nasal polyposis in aspirin-sensitive Hungarian individuals: conclusions of a genetic study with multiple stratifications. Int Immunol 25(6):383–388

    Article  CAS  PubMed  Google Scholar 

  10. Otto BA, Wenzel SE (2008) The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg 16(3):270–274

    Article  PubMed  Google Scholar 

  11. Soni NJ, Samson DJ, Galaydick JL, Vats V, Huang ES, Aranson N, Pitrak D (2013) Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med 8(9):530–540

    Article  PubMed  Google Scholar 

  12. Samsudin I, Vasikaran SD (2017) Clinical utility and measurement of procalcitonin. Clin Biochem Rev 38(2):59–68

    PubMed  PubMed Central  Google Scholar 

  13. Iankova I, Thompson-Leduc P, Kirson NY, Rice B, Hey J, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P (2018) Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis. Crit Care Med ​46(5):691–698

    Article  CAS  PubMed  Google Scholar 

  14. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206–217

    Article  CAS  PubMed  Google Scholar 

  15. Gilbert DN (2011) Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 52(Suppl 4):346–350

    Article  CAS  Google Scholar 

  16. Brunkhorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24(8):888–889

    Article  CAS  PubMed  Google Scholar 

  17. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79(6):1605–1608

    CAS  PubMed  Google Scholar 

  18. Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J (2005) Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171(1):48–53

    Article  PubMed  Google Scholar 

  19. Figueiredo CR, Silva IDC, Weckx LLM (2008) Inflammatory genes in nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 16:18–21

    Article  PubMed  Google Scholar 

  20. Maxfield AZ, Landegger LD, Brook CD, Lehmann AE, Campbell AP, Bergmark RW, Stankovic KM, Metson R (2018) Periostin as a biomarker for nasal polyps in chronic rhinosinusitis. Otolaryngol Head Neck Surg 158(1):181–186

    Article  PubMed  Google Scholar 

  21. Matsusaka M, Kabata H, Fukunaga K, Suzuki Y, Masaki K, Mochimaru T et al (2015) Phenotype of asthma related with high serum periostin levels. Allergol Int 64:175–180

    Article  CAS  PubMed  Google Scholar 

  22. Psaltis AJ, Bruhn MA, Ooi EH, Tan LW, Wormald PJ (2007) Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis. Laryngoscope 117(11):2030–2035

    Article  CAS  PubMed  Google Scholar 

  23. Ma Y, Zheng C, Shi L (2018) The role of YKL 40 in the pathogenesis of CRS with nasal polyps. Eur Arch Oto Rhino Laryngol 275(2):431–438

    Article  Google Scholar 

  24. Lechapt-Zalcman E, Coste A, d’Ortho MP, Frisdal E, Harf A, Lafuma C, Escudier E (2001) Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193:233–241

    Article  CAS  PubMed  Google Scholar 

  25. Lee YM, Kim SS, Kim HA, Suh YJ, Lee SK, Nahm DH, Park HS (2003) Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 18:97–102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Bhandari A, Takeuchi K, Suzuki S, Harada T, Hayashi S, Imanaka-Yoshida K, Yoshida T, Majima Y (2004) Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol 124:1165–1170

    Article  CAS  PubMed  Google Scholar 

  27. Becker KL, Snider R, Nylen ES (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159:253–264

    Article  CAS  PubMed  Google Scholar 

  28. Whang KT, Vath SD, Becker KL, Snider RH, Nylen ES, Muller B, Li Q, Tamarkin L, White JC (2000) Procalcitonin and pro-inflammatory cytokine interactions in sepsis. Shock 14:73–78

    Article  CAS  PubMed  Google Scholar 

  29. Redl H, Schiesser A, Tögel E, Assicot M, Bohuon C (2001) Possible role of TNF on procalcitonin release in a baboon model of sepsis. Shock 16: 25–27

    Article  Google Scholar 

  30. Araujo M, Doi S, Palant CE, Nylen ES, Becker KL (2013) Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury. Inflamm Res 62(10):887–894

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate all the authors who have made efforts in the whole program, and also thank all the researchers of the primary studies. We would like to thank Ertan Koç for his contributions as all authors in this study.

Author information

Authors and Affiliations

  1. Department of Otorhinolarnyngology, University of Health Sciences, Istanbul Education and Research Hospital, Abdurrahman Nafiz Gürman Street, Samatya, 34500, Fatih/İstanbul, Turkey

    Suat Bilici, Zehra Cinar, Ozgur Yigit & Mustafa Cakir

  2. Otorhinolaryngology Clinic, Luleburgaz State Hospital, Kirklareli, Turkey

    Enes Yigit

  3. Department of Medical Biochemistry, Medical Faculty Cerrahpaşa, University of Istanbul, Istanbul, Turkey

    Hafize Uzun

Authors
  1. Suat Bilici
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zehra Cinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ozgur Yigit
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mustafa Cakir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Enes Yigit
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hafize Uzun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suat Bilici.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bilici, S., Cinar, Z., Yigit, O. et al. Does procalcitonin have a role in the pathogenesis of nasal polyp?. Eur Arch Otorhinolaryngol 276, 1367–1372 (2019). https://doi.org/10.1007/s00405-019-05326-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-019-05326-7

Keywords

Search

Navigation